Louise Rodino-Klapac
Overview
Louise Rodino-Klapac received an average of $8M in total compensation, including $526K in salary, at Sarepta Therapeutics between 2020 and 2021.
Source: SEC filings on April 25, 2022 and April 20, 2021.
Related executives
We found 30 more executives who work or worked at Sarepta Therapeutics.
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
David Howton
Sarepta Therapeutics
General Counsel
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
Joseph Bratica
Sarepta Therapeutics